NEW YORK (GenomeWeb News) – A pair of investment banks today upgraded Affymetrix’s stock one day after a court found its principal rival Illumina guilty of infringing five of its patents.
 
News of the verdict, which forced Illumina to pay Affy $16.7 million in royalties for past sales, continued to buoy Affy’s shares, which were up 6.5 percent, or $1.70, at $28.31 in mid-afternoon trading today.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.